These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36041973)

  • 21. [Guideline-based thermal ablation of hepatocellular carcinoma].
    Mahnken AH
    Radiologe; 2022 Mar; 62(3):219-224. PubMed ID: 35037979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progression.
    McDevitt JL; Collard MD; Murphy RP; Sutphin PD; Yopp AC; Singal AG; Kalva SP
    Clin Imaging; 2020 Nov; 67():146-151. PubMed ID: 32659600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microwave ablation of hepatocellular carcinoma.
    Liang P; Wang Y
    Oncology; 2007; 72 Suppl 1():124-31. PubMed ID: 18087193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term survival of mice with hepatocellular carcinoma after pulse power ablation with nanosecond pulsed electric fields.
    Chen X; Zhuang J; Kolb JF; Schoenbach KH; Beebe SJ
    Technol Cancer Res Treat; 2012 Feb; 11(1):83-93. PubMed ID: 22181334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic Hepatectomy (with or without Robotic Assistance) versus Radiofrequency Ablation as a Minimally Invasive Treatment for Very Early-Stage or Early-Stage Hepatocellular Carcinoma.
    Chong CC; Lee KF; Chu CM; Chan AW; Yu SC; Lai PB
    Dig Surg; 2020; 37(1):65-71. PubMed ID: 30917378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locally ablative therapies for primary and metastatic liver cancer.
    Li D; Kang J; Madoff DC
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):931-45. PubMed ID: 24746315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
    Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The laparoscopic approach for radiofrequency ablation of hepatocellular carcinoma--indication, technique and results.
    Herbold T; Wahba R; Bangard C; Demir M; Drebber U; Stippel DL
    Langenbecks Arch Surg; 2013 Jan; 398(1):47-53. PubMed ID: 23093087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease.
    Nguyen N; Rode A; Trillaud H; Aubé C; Manichon AF; Hocquelet A; Paisant A; Dao T; Nahon P; Ganne-Carrié N; Blaise L; Cauchy F; Sutter O; Séror O; Nault JC
    Liver Int; 2022 Apr; 42(4):905-917. PubMed ID: 34894060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of microwave ablation and radiofrequency ablation in the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Dou Z; Lu F; Ren L; Song X; Li B; Li X
    Medicine (Baltimore); 2022 Jul; 101(30):e29321. PubMed ID: 35905207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally invasive local therapies for liver cancer.
    Li D; Kang J; Golas BJ; Yeung VW; Madoff DC
    Cancer Biol Med; 2014 Dec; 11(4):217-36. PubMed ID: 25610708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
    Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
    Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New approach for hepatocellular carcinoma treatment.
    Tabacelia D; Stroescu C; Dumitru R; Grigorescu RR; Martiniuc A; Husar-Sburlan IA; Copca N
    J Med Life; 2022 Jan; 15(1):138-143. PubMed ID: 35186148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Yu Q; Liu C; Navuluri R; Ahmed O
    Abdom Radiol (NY); 2021 Sep; 46(9):4467-4475. PubMed ID: 33870454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
    Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
    HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Safety and Efficacy of Nanosecond Pulsed Electric Field in Patients With Hepatocellular Carcinoma: A Prospective Phase 1 Clinical Study Protocol.
    Xu M; Xu D; Dong G; Ren Z; Zhang W; Aji T; Zhao Q; Chen X; Jiang T
    Front Oncol; 2022; 12():869316. PubMed ID: 35912221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.